The Food and Drug Administration continues to detain a broad range of food and other regulated products from Mainland China and Hong Kong as part of its mission to prevent the importation of food, drugs, biologics, cosmetics, medical devices and radiation-emitting electronic products that fail to meet the requirements of the Federal Food, Drug, and Cosmetic Act.

The Administrative Committee of the Guangzhou Development District and the People’s Government of the Huangpu District of Guangzhou Municipality recently issued a notice outlining certain measures to promote high-quality development in the biomedicine industry (Sui Pu Fu Gui No. 9 [2025]). These measures, collectively referred to as the “Biomedicine 3.0” policy, apply to enterprises, institutions, unincorporated organisations and other entities in the biomedicine industry, as well as individuals working in such entities, in the Guangzhou Development District and industry parks under its management (together referred to as “the District”) in compliance with relevant regulations. The measures took effect on 23 July 2025 and will remain in force for three years.

Lack of familiarity, a reluctance to experiment and even widespread mistrust are hindering the take-up of AI-enabled tech by the elderly.

Hungary has a robust academic infrastructure, particularly in university spin-offs, HandInScan Zrt. is one of them which founded in 2012. Global Sales Director Dezső Nagy and Business Development Manager Csilla Nemeth discuss the company’s evolution from a startup to an international enterprise with users in more than 30 economies, the experience of working with distributors to increase market penetration, and its future business development.

Hungary’s medical devices sector, dominated by innovative SMEs, is a key player in Europe’s MedTech industry, exporting 85% of its production, primarily to the EU. The competitiveness strategy aims to boost domestic production and sustainability while navigating EU MDR challenges. Opportunities for collaboration with Hong Kong include leveraging trade networks, regulatory expertise, and investment to enhance global market access and innovation.

Hong Kong has been vigorously promoting collaboration among the research, academic and industry sectors in recent years to strengthen the application and commercialisation of scientific research achievements. Contin Technology Limited, explained how the company utilises the city’s unique advantages to launch self-developed products and introduce medical technology solutions from its overseas partners to meet critical needs in the elderly care and medical fields.

In order to promote the integration of technological and industrial innovation in the field of biomedicine and to accelerate the development, industrialisation and application of innovative drugs and medical devices, Guangdong’s Department of Industry and Information Technology, Health Commission, Healthcare Security Administration and Medical Products Administration have jointly issued a first-batch catalogue of innovative drugs and medical devices approved in the province, in accordance with the Action Plan on Further Promoting the High-Quality Development of Guangdong’s Biopharmaceutical Industry.

Including statistics of Medicine and Medical Device Sales of China in the past 6 years.

Speedy advances in innovation and technology and increasing maturity in the application of artificial intelligence, big data analytics, genomics and other technologies have expedited the growth of the healthcare industry worldwide.

On 1 July, the National Healthcare Security Administration and the National Health Commission jointly announced multiple measures to support the high-quality development of innovative drugs. Priority is to be given to supporting innovative drug research and development (R&D), the inclusion of new drugs in insurance drug catalogues and their use in clinical application, diversifying payment channels for innovative drugs, and more.